Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.
D000493:Allopurinol / Q000627:therapeutic use; D000634:Aminoquinolines / Q000627:therapeutic use; D000965:Antimony / Q000627:therapeutic use; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use; D003452:Cryosurgery; D006801:Humans; D007896:Leishmaniasis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D007897:Leishmaniasis, Mucocutaneous / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007978:Levamisole / Q000627:therapeutic use; D008081:Liposomes / Q000008:administration & dosage; D008536:Meglumine; D000077485:Meglumine Antimoniate; D008795:Metronidazole / Q000627:therapeutic use; D009547:Nifurtimox / Q000627:therapeutic use; D009942:Organometallic Compounds; D010640:Phenothiazines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D000634:Aminoquinolines; D008081:Liposomes; D009942:Organometallic Compounds; D010640:Phenothiazines; D008795:Metronidazole; D007978:Levamisole; D000493:Allopurinol; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony; D009547:Nifurtimox; D000967:Antimony Sodium Gluconate; D012293:Rifampin